uric acid has been researched along with 6-ketoprostaglandin f1 alpha in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clearfield, HR; Cooney, CG; Murthy, SN | 1 |
| Edlund, A; Fitzgerald, GA; Nowak, J; Wennmalm, A; Wennmalm, M | 1 |
| Clifton, P; Gordon, TP; James, MJ; Roberts-Thomson, PJ | 1 |
| Fine, IT; Newcombe, DS; Wigley, FM | 1 |
| Shimizu, K | 1 |
| Barden, AE; Beilin, LJ; Michael, C; Ritchie, J; Walters, BN | 1 |
| Chen, K; Cui, WY; Liu, GS; Long, CL; Pan, ZY; Qin, XC; Wang, H; Zhang, YF | 1 |
2 trial(s) available for uric acid and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Vascular effects of infused adenosine are not mediated by prostacyclin release in humans.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine; Adult; Epinephrine; Epoprostenol; Female; Gas Chromatography-Mass Spectrometry; Heart Rate; Hemodynamics; Humans; Hypoxanthine; Hypoxanthines; Inosine; Leg; Male; Regional Blood Flow; Uric Acid | 1987 |
Aquaretic effects of the nonpeptide V2 antagonist OPC-31260 in hydropenic humans.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aldosterone; Angiotensin II; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Atrial Natriuretic Factor; Benzazepines; Blood Pressure; Calcium; Creatinine; Dinoprostone; Epinephrine; Heart Rate; Humans; Male; Norepinephrine; Osmolar Concentration; Phosphates; Potassium; Sodium; Thromboxane B2; Uric Acid; Urine; Water; Water Deprivation | 1995 |
5 other study(ies) available for uric acid and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Hydrogen peroxide-induced alterations in prostaglandin secretion in the rat colon in vitro.
Topics: 6-Ketoprostaglandin F1 alpha; Adrenal Cortex Hormones; Animals; Antioxidants; Calcimycin; Colon; Epithelium; Hydrogen Peroxide; Indomethacin; Intestinal Mucosa; Male; Organ Culture Techniques; Oxidation-Reduction; Phospholipases A; Phospholipases A2; Rats; Rats, Inbred Strains; Reperfusion Injury; Thromboxane B2; Uric Acid | 1990 |
Lack of correlation between in vitro and in vivo effects of low density lipoprotein on the inflammatory activity of monosodium urate crystals.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Humans; In Vitro Techniques; Inflammation; Lipoproteins, LDL; Luminescent Measurements; Male; Neutrophils; Rats; Rats, Inbred Strains; Uric Acid | 1986 |
The role of the human synovial fibroblast in monosodium urate crystal-induced synovitis.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; 6-Ketoprostaglandin F1 alpha; Arachidonic Acids; Cells, Cultured; Crystallization; Dinoprostone; Fibroblasts; Humans; In Vitro Techniques; L-Lactate Dehydrogenase; Neutrophils; Phagocytosis; Prostaglandins E; Synovial Membrane; Synovitis; Uric Acid | 1983 |
Does a predisposition to the metabolic syndrome sensitize women to develop pre-eclampsia?
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Blood Pressure; Body Mass Index; Causality; Creatinine; Endothelin-1; Female; Heart Rate; Humans; Hyperlipidemias; Hypertension; Lipids; Parity; Pre-Eclampsia; Pregnancy; Retrospective Studies; Serum Albumin; Uric Acid | 1999 |
Activation of ATP-sensitive potassium channels protects vascular endothelial cells from hypertension and renal injury induced by hyperuricemia.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Angiotensins; Animals; Cells, Cultured; Disease Models, Animal; Endothelin-1; Endothelium, Vascular; Hypertension; Hyperuricemia; KATP Channels; Kidney; Kidney Diseases; Male; Nitric Oxide; Oxonic Acid; Propylamines; Rats; Rats, Sprague-Dawley; Urate Oxidase; Uric Acid; Xanthine Oxidase | 2008 |